Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.

Lyapunov exponents and phase diagrams reveal multi-factorial control over TRAIL-induced apoptosis.

Aldridge BB, Gaudet S, Lauffenburger DA, Sorger PK.

Mol Syst Biol. 2011 Nov 22;7:553. doi: 10.1038/msb.2011.85.

2.

Caspase-3 cleaves XIAP in a positive feedback loop to sensitize melanoma cells to TRAIL-induced apoptosis.

Hörnle M, Peters N, Thayaparasingham B, Vörsmann H, Kashkar H, Kulms D.

Oncogene. 2011 Feb 3;30(5):575-87. doi: 10.1038/onc.2010.434. Epub 2010 Sep 20.

PMID:
20856198
3.

Quantitative analysis of pathways controlling extrinsic apoptosis in single cells.

Albeck JG, Burke JM, Aldridge BB, Zhang M, Lauffenburger DA, Sorger PK.

Mol Cell. 2008 Apr 11;30(1):11-25. doi: 10.1016/j.molcel.2008.02.012.

4.

STL-based analysis of TRAIL-induced apoptosis challenges the notion of type I/type II cell line classification.

Stoma S, Donzé A, Bertaux F, Maler O, Batt G.

PLoS Comput Biol. 2013;9(5):e1003056. doi: 10.1371/journal.pcbi.1003056. Epub 2013 May 9.

5.
7.

Intracellular signaling dynamics during apoptosis execution in the presence or absence of X-linked-inhibitor-of-apoptosis-protein.

O'Connor CL, Anguissola S, Huber HJ, Dussmann H, Prehn JH, Rehm M.

Biochim Biophys Acta. 2008 Oct;1783(10):1903-13. doi: 10.1016/j.bbamcr.2008.05.025. Epub 2008 Jun 11.

8.

Targeted therapy of the XIAP/proteasome pathway overcomes TRAIL-resistance in carcinoma by switching apoptosis signaling to a Bax/Bak-independent 'type I' mode.

Gillissen B, Richter A, Richter A, Overkamp T, Essmann F, Hemmati PG, Preissner R, Belka C, Daniel PT.

Cell Death Dis. 2013 May 23;4:e643. doi: 10.1038/cddis.2013.67.

9.

Tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL) induced mitochondrial pathway to apoptosis and caspase activation is potentiated by phospholipid scramblase-3.

Ndebele K, Gona P, Jin TG, Benhaga N, Chalah A, Degli-Esposti M, Khosravi-Far R.

Apoptosis. 2008 Jul;13(7):845-56. doi: 10.1007/s10495-008-0219-4.

10.

Targeting the apoptotic machinery in pancreatic cancers using small-molecule antagonists of the X-linked inhibitor of apoptosis protein.

Karikari CA, Roy I, Tryggestad E, Feldmann G, Pinilla C, Welsh K, Reed JC, Armour EP, Wong J, Herman J, Rakheja D, Maitra A.

Mol Cancer Ther. 2007 Mar;6(3):957-66. Epub 2007 Mar 5.

11.
12.

Smac/DIABLO release from mitochondria and XIAP inhibition are essential to limit clonogenicity of Type I tumor cells after TRAIL receptor stimulation.

Maas C, Verbrugge I, de Vries E, Savich G, van de Kooij LW, Tait SW, Borst J.

Cell Death Differ. 2010 Oct;17(10):1613-23. doi: 10.1038/cdd.2010.39. Epub 2010 Apr 16.

14.

A mitochondrial block and expression of XIAP lead to resistance to TRAIL-induced apoptosis during progression to metastasis of a colon carcinoma.

Ndozangue-Touriguine O, Sebbagh M, Mérino D, Micheau O, Bertoglio J, Bréard J.

Oncogene. 2008 Oct 9;27(46):6012-22. doi: 10.1038/onc.2008.197. Epub 2008 Jun 16.

PMID:
18560353
15.

X-linked inhibitor regulating TRAIL-induced apoptosis in chemoresistant human primary glioblastoma cells.

Roa WH, Chen H, Fulton D, Gulavita S, Shaw A, Th'ng J, Farr-Jones M, Moore R, Petruk K.

Clin Invest Med. 2003 Oct;26(5):231-42.

PMID:
14596484
16.

Modeling a snap-action, variable-delay switch controlling extrinsic cell death.

Albeck JG, Burke JM, Spencer SL, Lauffenburger DA, Sorger PK.

PLoS Biol. 2008 Dec 2;6(12):2831-52. doi: 10.1371/journal.pbio.0060299.

17.

Combined inhibition of FLIP and XIAP induces Bax-independent apoptosis in type II colorectal cancer cells.

Wilson TR, McEwan M, McLaughlin K, Le Clorennec C, Allen WL, Fennell DA, Johnston PG, Longley DB.

Oncogene. 2009 Jan 8;28(1):63-72. doi: 10.1038/onc.2008.366. Epub 2008 Sep 29.

PMID:
18820704
18.

Fas death receptor signalling: roles of Bid and XIAP.

Kaufmann T, Strasser A, Jost PJ.

Cell Death Differ. 2012 Jan;19(1):42-50. doi: 10.1038/cdd.2011.121. Epub 2011 Sep 30. Review.

19.
Items per page

Supplemental Content

Write to the Help Desk